Pharma & Healthcare

Global Iloprost Drugs Market Research Report 2025

The global market for Iloprost Drugs was valued at US$ 87.2 million in the year 2024 and is projected to reach a revised size of US$ 78 million by 2031, growing at a CAGR of -1.6% during the forecast period.
Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud"s phenomenon and other diseases in which the blood vessels are constricted and blood can"t flow to the tissues.
North America is estimated to have a major share in the global market with 75%.
This report aims to provide a comprehensive presentation of the global market for Iloprost Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iloprost Drugs.
The Iloprost Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Iloprost Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Iloprost Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Actelion (J & J)
Bayer AG
Segment by Type
Inhaled
Intravenous
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Iloprost Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Iloprost Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Inhaled
1.2.3 Intravenous
1.3 Market by Application
1.3.1 Global Iloprost Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Iloprost Drugs Market Perspective (2020-2031)
2.2 Global Iloprost Drugs Growth Trends by Region
2.2.1 Global Iloprost Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Iloprost Drugs Historic Market Size by Region (2020-2025)
2.2.3 Iloprost Drugs Forecasted Market Size by Region (2026-2031)
2.3 Iloprost Drugs Market Dynamics
2.3.1 Iloprost Drugs Industry Trends
2.3.2 Iloprost Drugs Market Drivers
2.3.3 Iloprost Drugs Market Challenges
2.3.4 Iloprost Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Iloprost Drugs Players by Revenue
3.1.1 Global Top Iloprost Drugs Players by Revenue (2020-2025)
3.1.2 Global Iloprost Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Iloprost Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Iloprost Drugs Revenue
3.4 Global Iloprost Drugs Market Concentration Ratio
3.4.1 Global Iloprost Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Iloprost Drugs Revenue in 2024
3.5 Global Key Players of Iloprost Drugs Head office and Area Served
3.6 Global Key Players of Iloprost Drugs, Product and Application
3.7 Global Key Players of Iloprost Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Iloprost Drugs Breakdown Data by Type
4.1 Global Iloprost Drugs Historic Market Size by Type (2020-2025)
4.2 Global Iloprost Drugs Forecasted Market Size by Type (2026-2031)
5 Iloprost Drugs Breakdown Data by Application
5.1 Global Iloprost Drugs Historic Market Size by Application (2020-2025)
5.2 Global Iloprost Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Iloprost Drugs Market Size (2020-2031)
6.2 North America Iloprost Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Iloprost Drugs Market Size by Country (2020-2025)
6.4 North America Iloprost Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Iloprost Drugs Market Size (2020-2031)
7.2 Europe Iloprost Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Iloprost Drugs Market Size by Country (2020-2025)
7.4 Europe Iloprost Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Iloprost Drugs Market Size (2020-2031)
8.2 Asia-Pacific Iloprost Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Iloprost Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Iloprost Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Iloprost Drugs Market Size (2020-2031)
9.2 Latin America Iloprost Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Iloprost Drugs Market Size by Country (2020-2025)
9.4 Latin America Iloprost Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Iloprost Drugs Market Size (2020-2031)
10.2 Middle East & Africa Iloprost Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Iloprost Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Iloprost Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Actelion (J & J)
11.1.1 Actelion (J & J) Company Details
11.1.2 Actelion (J & J) Business Overview
11.1.3 Actelion (J & J) Iloprost Drugs Introduction
11.1.4 Actelion (J & J) Revenue in Iloprost Drugs Business (2020-2025)
11.1.5 Actelion (J & J) Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Details
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Iloprost Drugs Introduction
11.2.4 Bayer AG Revenue in Iloprost Drugs Business (2020-2025)
11.2.5 Bayer AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Iloprost Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Inhaled
Table 3. Key Players of Intravenous
Table 4. Global Iloprost Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Iloprost Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Iloprost Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Iloprost Drugs Market Share by Region (2020-2025)
Table 8. Global Iloprost Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Iloprost Drugs Market Share by Region (2026-2031)
Table 10. Iloprost Drugs Market Trends
Table 11. Iloprost Drugs Market Drivers
Table 12. Iloprost Drugs Market Challenges
Table 13. Iloprost Drugs Market Restraints
Table 14. Global Iloprost Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Iloprost Drugs Market Share by Players (2020-2025)
Table 16. Global Top Iloprost Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iloprost Drugs as of 2024)
Table 17. Ranking of Global Top Iloprost Drugs Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Iloprost Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Iloprost Drugs, Headquarters and Area Served
Table 20. Global Key Players of Iloprost Drugs, Product and Application
Table 21. Global Key Players of Iloprost Drugs, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Iloprost Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Iloprost Drugs Revenue Market Share by Type (2020-2025)
Table 25. Global Iloprost Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Iloprost Drugs Revenue Market Share by Type (2026-2031)
Table 27. Global Iloprost Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Iloprost Drugs Revenue Market Share by Application (2020-2025)
Table 29. Global Iloprost Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Iloprost Drugs Revenue Market Share by Application (2026-2031)
Table 31. North America Iloprost Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Iloprost Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Iloprost Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Iloprost Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Iloprost Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Iloprost Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Iloprost Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Iloprost Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Iloprost Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Iloprost Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Iloprost Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Iloprost Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Iloprost Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Iloprost Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Iloprost Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Actelion (J & J) Company Details
Table 47. Actelion (J & J) Business Overview
Table 48. Actelion (J & J) Iloprost Drugs Product
Table 49. Actelion (J & J) Revenue in Iloprost Drugs Business (2020-2025) & (US$ Million)
Table 50. Actelion (J & J) Recent Development
Table 51. Bayer AG Company Details
Table 52. Bayer AG Business Overview
Table 53. Bayer AG Iloprost Drugs Product
Table 54. Bayer AG Revenue in Iloprost Drugs Business (2020-2025) & (US$ Million)
Table 55. Bayer AG Recent Development
Table 56. Research Programs/Design for This Report
Table 57. Key Data Information from Secondary Sources
Table 58. Key Data Information from Primary Sources
Table 59. Authors List of This Report


List of Figures
Figure 1. Iloprost Drugs Picture
Figure 2. Global Iloprost Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Iloprost Drugs Market Share by Type: 2024 VS 2031
Figure 4. Inhaled Features
Figure 5. Intravenous Features
Figure 6. Global Iloprost Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Iloprost Drugs Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Iloprost Drugs Report Years Considered
Figure 11. Global Iloprost Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Iloprost Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Iloprost Drugs Market Share by Region: 2024 VS 2031
Figure 14. Global Iloprost Drugs Market Share by Players in 2024
Figure 15. Global Top Iloprost Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iloprost Drugs as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Iloprost Drugs Revenue in 2024
Figure 17. North America Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Iloprost Drugs Market Share by Country (2020-2031)
Figure 19. United States Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Iloprost Drugs Market Share by Country (2020-2031)
Figure 23. Germany Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Iloprost Drugs Market Share by Region (2020-2031)
Figure 31. China Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Iloprost Drugs Market Share by Country (2020-2031)
Figure 39. Mexico Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Iloprost Drugs Market Share by Country (2020-2031)
Figure 43. Turkey Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Iloprost Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Actelion (J & J) Revenue Growth Rate in Iloprost Drugs Business (2020-2025)
Figure 47. Bayer AG Revenue Growth Rate in Iloprost Drugs Business (2020-2025)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies